Est. 2001·3,000+ placements · six offices · four regions
Capital Raisingcurated sourcedetected 2026-06-04 · confidence 95%

Last updated

Coralogix: Capital Raising

Coralogix closed $200m Series F funding round, bringing total capital raised to $550m. Co-led by Advent, CPPIB, and Greenfield. Focused on AI-driven observability platform expansion.

Source: ETtech (Economic Times)

What happened
Coralogix closed $200m Series F funding round, bringing total capital raised to $550m. Co-led by Advent, CPPIB, and Greenfield. Focused on AI-driven observability platform expansion.
Who
Coralogix · United States & Canada
When
2026-06-04
So what
At $550m in total capital across six rounds, Coralogix has moved well past the point where product-market fit is the question.

The leadership read

At $550m in total capital across six rounds, Coralogix has moved well past the point where product-market fit is the question. The Series F commits the company to a harder operational problem: sustaining full-fidelity ingestion at petabyte scale across eight regions while simultaneously building out an agentic layer, Olly, MCP, CLI, that turns observability data into autonomous operational decisions. That is two distinct engineering bets running in parallel, each with its own scaling economics, and the customer base spanning GovCloud, fintech, and AI infrastructure means compliance surface area is expanding alongside product scope. This is one of twelve capital-raising signals we have tracked across AI infrastructure and enterprise software in the last 90 days. The most structurally comparable at scale are ThreatLocker's $190m Series F in cybersecurity infrastructure and Stack's A$5.9bn data centre financing facility, both pointing to the same underlying thesis: enterprises are re-platforming core technical infrastructure around AI workloads, and capital is concentrating in the vendors positioned as foundational layers rather than point solutions. The pattern is consistent with late-stage consolidation pressure, where the largest rounds go to platforms that can argue architectural necessity rather than feature advantage. Companies reaching this stage of capital concentration in AI-native infrastructure consistently face rising demand for leadership at the intersection of enterprise commercial scale and technical architecture, specifically, go-to-market leaders who can sell platform-layer arguments to infrastructure buyers, product leaders who can manage a dual roadmap across data infrastructure and agentic tooling, and regulatory and compliance operations leadership capable of holding GovCloud and regulated-sector commitments at global scale.

Market context: The wider read — a Talent Market Index of 122.7 (Hot), up 17.8 month-on-month — shows Americas signal flow rising (+34.4pts).

Coralogix: 0 signals in the last 90 days; 0.1% of MitchelLake's Asia signal flow; 2 tracked across 1 days.

MitchelLake in this thematic

Also at Coralogix →

More signals across Americas

Capital Raising · Americas

Antheia →

Antheia, an advanced biosynthesis pharmaceutical manufacturer, secured an $80 million conditional funding commitment from the Department of War's Office of Strategic Capital to support domestic onshoring of critical medicine supply chains.

Capital Raising · Americas

Klook Technology →

Hong Kong-based travel booking platform Klook Technology has filed to withdraw its US IPO, which it had filed for in November 2025.

Capital Raising · Americas

Strive →

Strive priced an upsized $630M IPO of SATS preferred stock.

Capital Raising · Americas

Swamp Club →

San Francisco-based AI agent platform Swamp Club raised a $7M seed round led by Amplify Partners, with Encoded Ventures and angels participating. Funds will scale its behavior-centric AI agent platform for enterprise production use.

Capital Raising · Americas

EMode Photonix →

Boulder, Colorado photonics simulation software startup EMode Photonix raised a $1M pre-seed round led by Ground State Ventures, with Harlow Capital Management participating.

Capital Raising · Americas

Frazier Life Sciences Acquisition Corp →

Frazier Life Sciences is taking a biotech-focused SPAC public on Nasdaq, a blank-check vehicle raising capital to acquire a life sciences company.

Where this lands in our work

Weekly briefing

Track companies like Coralogix — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record